Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Drugs Used in HF
Quiz 6
| Question | Answer |
|---|---|
| Group of drugs composed of digitalis, a substance which occurs naturally in the foxglove plant. Have narrow therapeutic range. Widespread use for 200 years. | Cardiac Glycosides |
| Cardiac Glycosides are also known as | Inotropes |
| Digoxin is what type of drug? | Cardiac Glycosides (Inotropes) |
| Absorption of this drug varies widely between manufacturers. Once absorbed or given IV, takes 8 hr to reach tissue binding sites. Have long half-lives; several days for therapeutic effect. May receive loading dose. | Cardiac Glycosides (Inotropes) = DIGOXIN |
| Positive inotropic, and negative inotropic and dromotropic effects. Stimulates PNS, slows heart rate, and slows conduction through AV node. | Cardiac Glycosides (Inotropes) = DIGOXIN |
| Used to treat CHF, A-fib, atrial flutter, and paroxysmal atrial tachycardia. May improve cardiac hemodynamics when used with diuretics and vasodilators in mild to moderate HF. | Cardiac Glycosides (Inotropes) = DIGOXIN |
| `Will increase myocardial O2 demand, so benefits must outweigh risk before prescribing in post MI for supraventricular arrhythmias. | Cardiac Glycosides (Inotropes) = DIGOXIN |
| Quinidine may double serum levels by reducing this drug's rate of elimination. Verapamil enhances effects of this drug. | Cardiac Glycosides (Inotropes) = DIGOXIN |
| Antacids decrease absorption of this drug if taken at the same time, so doses should be staggered. | Cardiac Glycosides (Inotropes) = DIGOXIN |
| Therapeutic range of Digoxin is _______ng/dL | 0.5-2.0 |
| Hypokalemia may predispose patients to toxicity. Signs include N/V, diarrhea, restlessness, irritability, cardiac arrhythmias (bradycardia, atrial, and ventricular). | Cardiac Glycosides (Inotropes) = Digoxon |
| Cariotonic-inotropic agents used in the short-term management of HF not controlled by digoxin, diuretics, and vasodilators. | Phosphodiesterase Inhibitors |
| Drugs relax vascular smooth muscle to produce vasodilation, decrease preload and afterload. Given by continuous IV infusion. | Phosphodiesterase Inhibitors |
| What type of drug is Amrinone? | Phosphodiesterase Inhibitors |
| What type of drug is Milrinone? | Phosphodiesterase Inhibitors |
| Group of drugs that may be used in severe HF to provide circulatory support. Strengthen myocardial contraction. | Adrenergic Agents |
| Use of minimal effective dose of this group of drugs is recommended, because tachycardia and HTN can cause increased cardiac workload and increased myocardial O2 consumption. | Adrenergic Agents |
| Dopamine is what type of drug? | Adrenergic Agents |
| Dobutamine is what type of drug? | Adrenergic Agents |
| Drugs of 1st choice in treating all four NY Heart Association classifications. Act to block the conversion of Angiotensin I to Angiotensin II, thus producing dilation of both veins and arteries, and decreased retention of Na and H2O. | Angiotensin-converting Enzyme (ACE) Inhibitors |
| This group of drugs results in decreased preload and afterload, decreases cardiac workload, and increases perfusion of body organs and tissues. Can be given with or without digoxin. | Angiotensin-converting Enzyme (ACE) Inhibitors |
| What type of drug is Captopril? | Angiotensin-converting Enzyme (ACE) Inhibitors |
| What type of drug is Lisinopril? | Angiotensin-converting Enzyme (ACE) Inhibitors |
| What type of drug is Quinapril? | Angiotensin-converting Enzyme (ACE) Inhibitors |
| What type of drug is Enalapril? | Angiotensin-converting Enzyme (ACE) Inhibitors |
| Used in treatment of chronic HF to suppress activation of SNS and excessive catacholamine response that eventually damages myocardial cells. | Beta-adrenergic Blocking Agents |
| Over time, use of this group of drugs results in the heart returning to normal shape and function (reverse remodeling), and cardiac output increases. | Beta-adrenergic Blocking Agents |
| This group of drugs is not used in acute HF because of initial decrease in myocardial contractility. May be started once acute symptoms relieved. | Beta-adrenergic Blocking Agents |
| This group of drugs usually starts in low doses, then dosage increased over 2 weeks. Used with ACE inhibitor. | Beta-adrenergic Blocking Agents |
| What type of drug is Bisoprolol? | Beta-adrenergic Blocking Agents |
| What type of drug is Carvedilol? | Beta-adrenergic Blocking Agents |
| What type of drug is Metaprolol? | Beta-adrenergic Blocking Agents |
| Group of drugs used to relieve edema by decreasing extracellular fluid volume and increasing excretion of Na and H2O, thus decreasing preload. | Diuretics |
| This group of drugs may be given PO or IV. Initial treatment in acute failure. Relieved symptoms of HF but does not improve left ventricular function. | Diuretics |
| Group of drugs includes ACE inhibitors, angiotensin receptor antagonists, nitrates (venous dilators), and arterial vasodilators (such as Hydralazoine). | Vasodilators |
| Group of drugs acts to decrease preload and afterload depending on the agent used. May combine isosorbide (a nitrate) with hydralazine to decrease both preload and afterload. | Vasodilators |
| Group of drugs may be taken PO for clients with chronic HF, or IV for those in severe HF. | Vasodilators |
| This specific drug is a combination of hydralazine and isosorbide, which received approval in 2005 for treating HF, especially in African-Americans. | BiDil |
| Group of drugs produced by recombinant DNA technology; it is identical to endogenous human BNP, which is secreted by the ventricles in response to fluid and pressure overload. | Human B-Type Natriuretic Peptide (BNP) |
| Group of drugs compensates for deteriorating cardiac function by reducing preload and afterload, increases diuresis, and suppresses the renin-angiotensin-aldesterone mechanism. | Human B-Type Natriuretic Peptide (BNP) |
| Nesteritide is the first drug in this class to be used in the treatment of HF | Human B-Type Natriuretic Peptide (BNP) |
| What type of drug is Nesteritide? | Human B-Type Natriuretic Peptide (BNP) |
| Group of drug relaxes blood vessels and improves blood flow by targeting the neurohormone endothelin-1 that is produced in excess in HF. Other drugs in this class are being studied (additional data beeded to support use in HF). | Endothelin Receptor Antagonists |
| What type of drug is Bosentan? (Note additional info on answer side!) | Endothelin Receptor Antagonists (Note: This drug is approved by the FDA for treatment of pulmonary HTN) |
| Upon evaluation of the patient with HF, what therapeutic effects may we see with use of HF drugs? | Breath easier, decreased edema, improved activity tolerance |
| What should we assess the pt for with HF? | Symptoms of HF, breath sounds, edema, dyspnea, HTN, confusion, fatigue |
| What considerations should be made in implementation of drug administration for HF? | Assess baseline apical HR and rhythm prior to each dose, hold for apical rate <60 and call MD, monitor serum digoxin levels, monitor for signs of dig toxicity. |
| What should we teach client who is taking meds for HF? | Take own pulse (call MD with pulse <60 and do not take med), take at same time every day and don't double missed doses, take same brand (DO NOT substitute), report s/s HF, report s/s dig toxicity. |
Created by:
mreedy
Popular Nursing sets